Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Vascular Diseases: full-pipeline trial registry
26 of 41 indexed Vascular Diseases trials are currently recruiting.
Corpus placement: #357 of 28,707 conditions by registered trial count.
41 US clinical trials · 26 currently recruiting · #357 of 28,707 conditions by registered trial count
Vascular Diseases: 41 US clinical trials tracked, 26 recruiting.
Vascular Diseases is the subject of 41 registered US clinical trials on ClinicalTrials.gov, 26 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is ReCor Medical, running 5 of these trials.
Enrollment posture brief
Registry condition vascular-diseases
OPEN 26 | RECR 63% | LATE 5 | EARLY 5 | RANK #357 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Advanced Melanoma (64% recruiting · 22 trials)
Vascular Diseases lists 26 open slots (63% of 41 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Vascular Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Vascular Diseases is recruiting above its size-band peers.
26 of 41 indexed trials (63.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Vascular Diseases trials is spread across many organizations.
ReCor Medical accounts for 5 of 41 trials (12.2%). 29 distinct sponsors appear on at least one study for this condition label.
-
Typical Vascular Diseases enrolment sits around 170 participants.
Median target enrolment is 170 among the 41 trials that report a genuine target (sentinel values excluded). 14 of those (34.1%) plan for fewer than 100 participants.
-
Vascular Diseases research is mostly interventional.
29 interventional and 12 observational studies make up this index (70.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
41 total, page 1 of 1
Factors Affect Outcomes in Cardiovascular Surgery
University of California, Davis
NCT01932411
Natural History of Stroke: Cause and Development
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00009243
Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation
Medtronic Vascular
NCT07174622
The RADIANCE CED Study
ReCor Medical
NCT07231757
Thrombosis and Inflammation in Vessels Initiative (TIVI)
National Heart, Lung, and Blood Institute (NHLBI)
NCT06552767
Global Paradise System US Post Approval Study
ReCor Medical
NCT06297291
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
AliveCor
NCT06271577
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Fundación EPIC
NCT07286578
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
University of Pittsburgh
NCT05655936
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
National Institute of Neurological Disorders and Stroke (NINDS)
NCT06615973
CLOSM Trial: Groin Closure Using Layered Option for Suture Material
The Cleveland Clinic
NCT06990425
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
C5 Biomedical
NCT06674980
SPYRAL GEMINI Pilot Study
Medtronic Vascular
NCT06907147
SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery
Vanderbilt University Medical Center
NCT05812755
Mechanisms of Pregnancy Vascular Adaptations
University of Wisconsin, Madison
NCT03806283
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients
University of Colorado, Denver
NCT05005793
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
University of Colorado, Denver
NCT04040959
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
OriCell Therapeutics Co.
NCT06271252
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
University of Colorado, Denver
NCT06140537
Treatment With Aspirin After Preeclampsia: TAP Trial
Malamo Countouris
NCT06281665
Passive Limb Movement Study
Medical College of Wisconsin
NCT05935670
Improving Blood Pressure Control in Stroke Patients by Increasing Access to a Home Blood Pressure Monitor
Stanford University
NCT05730465
Sildenafil to Reduce Vascular Remodeling During Left Ventricular Assist Device Support
Montefiore Medical Center
NCT06510322
Diabetic Neuropathy in Spinal Cord Stimulator Patients
University of Chicago
NCT04687215
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
University of California, Davis
NCT05236374
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Pulmovant
NCT07333183
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
Medtronic Vascular
NCT05198674
RADIANCE Continued Access Protocol
ReCor Medical
NCT05017935
A Study of the ReCor Medical Paradise System in Clinical Hypertension
ReCor Medical
NCT02649426
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
ReCor Medical
NCT03614260
A Study of Mosliciguat in PH-ILD
Pulmovant
NCT06635850
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
Inquis Medical
NCT05907564
Sleep and Vascular Health Study
Auburn University
NCT05918744
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
Medco Health Solutions
NCT00830570
Targeting of UnControlled Hypertension in Emergency Department
University of Illinois at Chicago
NCT03749499
pRESET for Occlusive Stroke Treatment
phenox
NCT03994822
Distributed Registry
Stanford University
NCT03898570
11C-PIB PET Study in MESA at Columbia University
José A. Luchsinger
NCT03981380
Vialize Use for the Reduction of Vascular Groin Incisional Dehiscence and Infection
University of Florida
NCT06032949
Effect of Thiazolidinedione Treatment Vascular Risk Markers
University of Arkansas
NCT00571506
Comparison of Time-Restricted Feeding Versus Grazing
Pennington Biomedical Research Center
NCT01895179
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 4 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Vascular Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Vascular Diseases trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Vascular Diseases page
41 registered trials, 26 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 26 Vascular Diseases trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- ReCor Medical sponsors the most Vascular Diseases trials on record, review their full trial history before evaluating a specific study. See ReCor Medical's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vascular Diseases condition card totals 41 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.